{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.89A>G",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "G",
            "position": "89"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "G",
            "position": "30"
          },
          "Description in input context": "c.89A>G (p.E30G)"
        },
        {
          "HGVS": "NM_000345.4:c.137G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "137"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "46"
          },
          "Description in input context": "c.137G>A (p.A46T)"
        },
        {
          "HGVS": "NM_000345.4:c.158A>T",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "A",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "53"
          },
          "Description in input context": "c.158A>T (p.A53T)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005071"
  },
  "Experiment Method": [
    {
      "Assay Method": "Thioflavin T fluorescence",
      "Material used": {
        "Material Source": "Synthetic",
        "Material Name": "α-synuclein protein",
        "Description": "The experiment was conducted using synthetic α-synuclein protein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.89A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The A30P mutation delays amyloid formation compared to wildtype α-synuclein."
        },
        {
          "Variant": "NM_000345.4:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The E46K mutation accelerates amyloid formation and oligomer formation compared to wildtype α-synuclein."
        },
        {
          "Variant": "NM_000345.4:c.158A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The A53T mutation accelerates amyloid formation and oligomer formation compared to wildtype α-synuclein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were conducted with multiple protein preparations."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer without α-synuclein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Lag phase of amyloid formation within 24 hours.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Lag phase of amyloid formation significantly shorter or longer than 24 hours.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Dot-blot analysis",
      "Material used": {
        "Material Source": "Synthetic",
        "Material Name": "α-synuclein protein",
        "Description": "The experiment was conducted using synthetic α-synuclein protein."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.89A>G",
          "Conclusion": "Normal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A30P-syn oligomers were observed only when both 20S and liposomes were present."
        },
        {
          "Variant": "NM_000345.4:c.137G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "E46K-syn oligomers were observed in all conditions tested."
        },
        {
          "Variant": "NM_000345.4:c.158A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "A53T-syn oligomers were observed in all conditions tested."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Experiments were conducted with multiple protein preparations."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer without α-synuclein was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Detection of oligomers within 24 hours.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Detection of oligomers significantly earlier or later than 24 hours.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}